- Condition: Amblyopia
Interventions: Drug: Placebo; Drug: Donepezil; Other: Patching
Sponsors: Children's Hospital Boston; Children's Hospital Boston
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: ABT-126; Drug: ABT-126; Drug: placebo
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Nicotine Addiction
Intervention: Drug: Galantamine ER
Sponsors: University of Pennsylvania; University of Pennsylvania
Recruiting - verified March 2012 - Condition: Parkinson's Disease
Intervention: Drug: Donepezil
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified January 2012 - Conditions: Parkinson's Disease; Mild Cognitive Impairment
Interventions: Drug: Exelon Patch (rivastigmine transdermal system); Drug: Placebo Patches
Sponsors: University of Pennsylvania; University of Pennsylvania
Recruiting - verified January 2012 - Condition: Cocaine Use Disorders
Interventions: Drug: High-dose donepezil; Drug: Low-dose donepezil; Drug: Selegiline; Drug: Placebo
Sponsors: Midwest Biomedical Research Foundation; Midwest Biomedical Research Foundation; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Condition: Addiction
Interventions: Drug: Galantamine; Drug: Placebo
Sponsors: Yale University; Yale University; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Surgical Procedures, Elective
Interventions: Drug: Sugammadex; Drug: Neostigmine; Drug: Glycopyrrolate
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: AZD3480
Sponsors: Targacept Inc.; Targacept Inc.
Recruiting - verified May 2012 - Condition: Heart Failure
Intervention: Drug: Pyridostigmine Bromide
Sponsors: New York University School of Medicine; New York University School of Medicine; Nathan Kline Institute for Psychiatric Research; Oklahoma State University Center for Health Sciences; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified August 2011 - Conditions: Posttraumatic Stress Disorder; Traumatic Brain Injury
Interventions: Drug: Methylphenidate Hydrochloride 20 mg; Drug: Placebo Capsule; Drug: Galantamine 12 mg
Sponsors: INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium; INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium; U.S. Army Medical Research and Materiel Command
Recruiting - verified January 2012 - Condition: Cocaine Dependence
Interventions: Drug: Oral tacrine; Drug: Oral placebo
Sponsors: Midwest Biomedical Research Foundation; Midwest Biomedical Research Foundation
Not yet recruiting - verified May 2012 - Condition: Cholinergic Function
Interventions: Drug: Scopolamine; Drug: Placebo; Drug: Donepezil
Sponsors: Hebrew Rehabilitation Center, Boston; Hebrew Rehabilitation Center, Boston
Recruiting - verified March 2012 - Conditions: Mild Cognitive Disorder; Mild Cognitive Impairment
Interventions: Drug: Exelon [rivastigmine] transdermal patch; Drug: Placebo patch
Sponsors: The Cleveland Clinic; The Cleveland Clinic
Recruiting - verified May 2012 - Conditions: Orthostatic Hypotension; Multiple System Atrophy
Interventions: Drug: Droxidopa; Drug: Pyridostigmine Bromide
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified December 2011 - Conditions: Dementia; Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: Galantamine; Drug: Rivastigmine
Sponsors: Regenstrief Institute, IU Center for Aging Research; Regenstrief Institute, IU Center for Aging Research; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified June 2011 - Condition: Parkinson's Disease
Interventions: Drug: Strattera; Drug: Exelon; Other: Placebo
Sponsors: Oregon Health and Science University; Oregon Health and Science University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2012 - Condition: Healthy
Interventions: Drug: CW 002; Drug: CW 002; Drug: CW 002
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified June 2011 - Condition: Dementia Alzheimer's Type
Interventions: Drug: SAR110894D; Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Smoking
Intervention: Drug: Donepezil
Sponsors: Abramson Cancer Center of the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified May 2012 - Condition: Biomarkers, Pharmacological
Interventions: Drug: Huperzine A; Drug: Donepezil; Drug: Galantamine; Other: Placebo
Sponsors: U.S. Army Medical Research and Materiel Command; U.S. Army Medical Research and Materiel Command; Walter Reed Army Institute of Research (WRAIR)
Recruiting - verified May 2012 - Condition: Fragile X Syndrome
Interventions: Drug: donepezil hydrochloride; Drug: sugar pill
Sponsors: Stanford University; Stanford University; National Institute of Mental Health (NIMH); Autism Speaks
Recruiting - verified July 2011 - Condition: Down Syndrome
Interventions: Drug: Rivastigmine; Other: Liquid Placebo
Sponsors: Duke University; Duke University; Taishoff Family Foundation
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Schizophrenia
Interventions: Drug: Galantamine; Drug: Galantamine or Placebo
Sponsors: University of Maryland; University of Maryland; National Institute of Mental Health (NIMH)
Recruiting - verified March 2012 - Conditions: Cocaine Dependence; Cocaine Addiction; Cocaine Abuse; Substance Abuse
Interventions: Drug: Placebo; Drug: Rivastigmine; Drug: Huperzine A; Drug: Rivastigmine; Drug: Huperzine A
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Ischemic Stroke
Interventions: Drug: donepezil; Drug: placebo
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Cocaine Dependence
Interventions: Drug: Galantamine; Drug: placebo
Sponsors: Yale University; Yale University; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Condition: Spinal Cord Injury
Intervention: Drug: Neostigmine
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Condition: Bipolar Disorder
Interventions: Drug: Galantamine-ER; Drug: Galantamine placebo
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH); Massachusetts General Hospital; Mount Sinai School of Medicine
Recruiting - verified January 2012 - Conditions: Diabetic Neuropathic Pain; Chronic Low Back Pain
Interventions: Drug: donepezil; Drug: duloxetine; Drug: donepezil 2.5 mg and duloxetine 30mg; Drug: placebo; Drug: gabapentin
Sponsors: Wake Forest University; Wake Forest University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2012 - Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012
 |
Cholinesterase Inhibitors Clinical Trials |
